Sfoglia per AUTORE
SHEN F
Collezione AOU Città della Salute di Torino
Items : 2
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma. in EJHaem / EJHaem. 2022 Feb 14;3(2):394-405. doi: 10.1002/jha2.394. eCollection 2022 May.
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Hagner P; Li Y; Sangha R; Shen F; Greenwald DR; Klein LM; Isufi I; Andorsky DJ; Corradini P; Kenkre VP; Boccomini C; Flinn IW; Santoro A; Witzig TE; Bijou F; Chavez JC; Kuruvilla J; Nastoupil LJ; Dobmeyer J; Gong N; Uttamsingh S; Pourdehnad M; Ribrag V;


